For pharmaceutical companies and CROs, the challenge is not simply to produce regulatory documents faster. It is to deliver clear, accurate and consistent content that supports regulatory review. Artificial intelligence (AI) can help with parts of that process, but efficiency must go hand in hand with scientific judgement and quality control.
